Skip to main content
AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc. — Investor Relations & Filings

Ticker · ANTX ISIN · US0373261058 US Manufacturing
Filings indexed 339 across all filing types
Latest filing 2026-04-22 Annual Report
Country US United States of America
Listing US ANTX

About AN2 Therapeutics, Inc.

https://www.an2therapeutics.com/

AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing treatments for rare, chronic, and serious infectious diseases with high unmet medical needs. The company utilizes its proprietary boron chemistry platform to create novel small molecule therapeutics. Its development pipeline includes boron-based compounds, such as its lead candidate epetraborole, which are being investigated as potential first-in-class or best-in-class therapies. The company's mission is to deliver high-impact drugs to improve global health outcomes, with potential applications extending to oncology.

Recent filings

Filing Released Lang Actions
ARS - AN2 Therapeutics, Inc. (0001880438) (Filer)
Annual Report
2026-04-22 English
DEF 14A - AN2 Therapeutics, Inc. (0001880438) (Filer)
Proxy Solicitation & Information Statement
2026-04-22 English
424B3 - AN2 Therapeutics, Inc. (0001880438) (Filer)
Prospectus
2026-04-20 English
S-3 - AN2 Therapeutics, Inc. (0001880438) (Filer)
Registration Form
2026-04-09 English
8-K - AN2 Therapeutics, Inc. (0001880438) (Filer)
Regulatory Filings
2026-04-09 English
D - AN2 Therapeutics, Inc. (0001880438) (Filer)
Regulatory Filings
2026-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.